Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lineage Cell Therapeutics | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪617.04M | -6.3x | 2.24 | ILA 324.60 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Compugen | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪577.32M | -16x | -0.22 | ILA 627.70 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Batm | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪427.91M | -258.6x | 1.53 | ILA 90.60 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oramed Pharma | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪365.15M | 4.6x | 0.02 | ILA 876 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BioLine RX | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪155.98M | -1.2x | -0.04 | ILA 13 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bonus Biogroup | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪137.82M | -5.1x | ILA 11.80 | -4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Enlivex | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪124.21M | -1.3x | -0.08 | ILA 573 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
DNA Group TR | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪108.88M | 7.2x | 0.02 | ILA 88.40 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pluri Inc | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪93.42M | -1.1x | -0.03 | ILA 1,835 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
XTL Bio | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪91.81M | -19.9x | -0.88 | ILA 7.50 | -9.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Matricelf | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪59.71M | ILA 371.20 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Evogene | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪52.94M | -0.6x | -0.02 | ILA 995.10 | 8.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kadimastem Ltd | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪36.34M | -20.3x | -0.04 | ILA 866.50 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Purple Biotech | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪28.30M | -0.3x | -0.01 | ILA 8.10 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nextage Therapeutics | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪20.72M | ILA 61.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Merchavia | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪11.56M | -1.2x | -0.33 | ILA 68.80 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Univo Pharma | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪2.84M | ILA 93,000 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Hadasit Bio | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪2.83M | -0.4x | -0.01 | ILA 25.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |